4489-3335 Screening compound: 4-(5-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-3-methylbenzoic acid

4489-3335 Screening compound: 4-(5-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-3-methylbenzoic acid
4489-3335 Screening compound: 4-(5-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-3-methylbenzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound 4489-3335
4-(5-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-3-methylbenzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4489-3335

Molecular Formula

C23H17NO4S2 (C23 H17 NO4 S2)

Compound Name

4-(5-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-3-methylbenzoic acid

IUPAC name

4-(5-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-13-thiazolidin-5-ylidene]methyl}furan-2-yl)-3-methylbenzoic acid

SMILES

Cc(cc(cc1)C(O)=O)c1-c1ccc(/C=C(\C(N2Cc3ccccc3)=O)/SC2=S)o1

InChI

InChI=1S/C23H17NO4S2/c1-14-11-16(22(26)27)7-9-18(14)19-10-8-17(28-19)12-20-21(25)24(23(29)30-20)13-15-5-3-2-4-6-15/h2-12H,13H2,1H3,(H,26,27)

InChI Key

DWXRGKVVJUXZKF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02627762

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.52

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.876

Distribution Coefficient, logD

2.641

Water Solubility, LogSw

-5.35

Polar Surface Area

52.420

Acid Dissociation Constant (pKa)

4.17

Base Dissociation Constant (pKb)

-2.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

4489-3335 in Drug Discovery

Included in Screening Libraries

Integrin Receptors Targeted library (1715 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Others
  • Phosphatases

References: we are preparing a list of scientific research reports with 4489-3335 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4489-3335?
Check Price and Availability of 4489-3335, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4489-3335 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4489-3335
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4489-3335
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4489-3335 available by request